Table 6.
Outcomes | <100 µg/L | ≥100, <300 µg/L | ≥300 µg/L | p for interaction |
---|---|---|---|---|
β (95% CI), p-value | ||||
FT3 | −0.0343 (−0.0771, 0.0084) | −0.1125 (−0.1463, −0.0788) ∗ ∗ ∗ | −0.0412 (−0.0940, 0.0115) | 0.007 |
TT4 | 0.1087 (−0.0200, 0.2373) | 0.1737 (0.0721, 0.2753) ∗ ∗ ∗ | 0.1016 (−0.0571, 0.2603) | 0.639 |
FT3/FT4 | −0.0801 (−0.1738, 0.0136) | −0.1481 (−0.2221, −0.0741) ∗ ∗ ∗ | −0.0796 (−0.1952, 0.0360) | 0.428 |
TG | −0.6181 (−3.9921, 2.7558) | 2.9681 (0.3038, 5.6324) ∗ ∗ | 0.5213 (−3.6415, 4.6840) | 0.229 |
Note: FT3, free triiodothyronine; FT4, free thyroxine; TT3, total triiodothyronine; TT4, total thyroxine; TG, thyroglobulin; and TGAb, thyroglobulin antibodies. ∗p < 0.05, ∗ ∗p < 0.01, ∗ ∗ ∗p < 0.001. Bold value signifies the statistically significant variables clearly distinguishable from those that are not.